(Q37707220)

22 August 2017

1 reference

title

In-silico approaches to multi-target drug discovery : computer aided multi-target drug design, multi-target virtual screening (English)

1 reference

22 August 2017

0 references

1 reference

1 reference

Boon Chuan Low

6

0 references

author name string

Xiao Hua Ma

1

1 reference

22 August 2017

Zhe Shi

2

1 reference

22 August 2017

Chunyan Tan

3

1 reference

22 August 2017

Yuyang Jiang

4

1 reference

22 August 2017

Mei Lin Go

5

1 reference

22 August 2017

Yu Zong Chen

7

1 reference

22 August 2017

publication date

11 March 2010

1 reference

22 August 2017

published in

Pharmaceutical Research

1 reference

22 August 2017

volume

27

1 reference

22 August 2017

issue

5

1 reference

22 August 2017

page(s)

739-749

1 reference

Crosstalk of oncogenic and prostanoid signaling pathways

22 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11095-010-0065-2

Inhibition of c-Src expression and activation in malignant pleural mesothelioma tissues leads to apoptosis, cell cycle arrest, and decreased migration and invasion

21 January 2018

1 reference

12 December 2020

Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity

1 reference

12 December 2020

Predicting the Predictability: A Unified Approach to the Applicability Domain Problem of QSAR Models

1 reference

12 December 2020

Development and experimental validation of a docking strategy for the generation of kinase-targeted libraries

1 reference

12 December 2020

A phase II study of flavopiridol (Alvocidib) in combination with docetaxel in refractory, metastatic pancreatic cancer

1 reference

12 December 2020

Comparison of imatinib, dasatinib, nilotinib and INNO-406 in imatinib-resistant cell lines

1 reference

12 December 2020

Collaborative filtering on a family of biological targets.

1 reference

12 December 2020

Combined treatment of bladder cancer cell lines with lapatinib and varying chemotherapy regimens--evidence of schedule-dependent synergy

1 reference

12 December 2020

The in vitro and in vivo effects of JNJ-7706621: a dual inhibitor of cyclin-dependent kinases and aurora kinases

1 reference

12 December 2020

Imatinib treatment for gastrointestinal stromal tumour (GIST).

1 reference

12 December 2020

Co-expression of receptor tyrosine kinases in esophageal adenocarcinoma and squamous cell cancer

1 reference

12 December 2020

Multiple signaling pathways must be targeted to overcome drug resistance in cell lines derived from melanoma metastases

1 reference

12 December 2020

The physicochemical challenges of designing multiple ligands

1 reference

12 December 2020

Novel paradigms for drug discovery: computational multitarget screening

1 reference

12 December 2020

5-HT reuptake inhibitors with 5-HT(1B/1D) antagonistic activity: a new approach toward efficient antidepressants

1 reference

12 December 2020

Comparative analysis of machine learning methods in ligand-based virtual screening of large compound libraries

1 reference

12 December 2020

Regulation of monoamine transporters: influence of psychostimulants and therapeutic antidepressants

1 reference

12 December 2020

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

1 reference

12 December 2020

Turning promiscuous kinase inhibitors into safer drugs

1 reference

12 December 2020

COMT-inhibition increases serum levels of dihydroxyphenylacetic acid (DOPAC) in patients with advanced Parkinson's disease

1 reference

12 December 2020

CHIR-258: a potent inhibitor of FLT3 kinase in experimental tumor xenograft models of human acute myelogenous leukemia

1 reference

12 December 2020

IQGAP proteins are integral components of cytoskeletal regulation

1 reference

12 December 2020

Virtual screening of Abl inhibitors from large compound libraries by support vector machines

1 reference

12 December 2020

Roscovitine inhibits differentiation and invasion in a three-dimensional skin reconstruction model of metastatic melanoma

1 reference

12 December 2020

Virtual screening of chemical libraries

1 reference

12 December 2020

Multicomponent therapeutics for networked systems

1 reference

12 December 2020

Phase II study of dasatinib in patients with metastatic castration-resistant prostate cancer

1 reference

12 December 2020

Analysis of activity space by fragment fingerprints, 2D descriptors, and multitarget dependent transformation of 2D descriptors.

1 reference

12 December 2020

Pyrroloisoquinoline antidepressants. 2. In-depth exploration of structure-activity relationships

1 reference

12 December 2020

Kinase-targeted library design through the application of the PharmPrint methodology

1 reference

12 December 2020

Recent advances in the development of multi-kinase inhibitors

1 reference

12 December 2020

IQGAP1-dependent signaling pathway regulates endothelial cell proliferation and angiogenesis

1 reference

12 December 2020

A support vector machines approach for virtual screening of active compounds of single and multiple mechanisms from large libraries at an improved hit-rate and enrichment factor

1 reference

12 December 2020

Vascular endothelial growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer: a review of recent clinical trials

1 reference

12 December 2020

Pazopanib, a VEGF receptor tyrosine kinase inhibitor for cancer therapy

1 reference

12 December 2020

CHIR-258, a novel, multitargeted tyrosine kinase inhibitor for the potential treatment of t(4;14) multiple myeloma.

1 reference

12 December 2020

Identifying regulatory networks by combinatorial analysis of promoter elements

1 reference

12 December 2020

Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy.

1 reference

12 December 2020

Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application

1 reference

12 December 2020

Characteristics of dasatinib- and imatinib-resistant chronic myelogenous leukemia cells

1 reference

12 December 2020

Pharmacophore modelling and virtual screening for identification of new Aurora-A kinase inhibitors

1 reference

12 December 2020

Unified QSAR and network-based computational chemistry approach to antimicrobials, part 1: multispecies activity models for antifungals

1 reference

12 December 2020

Sensitivity of oncogenic KIT mutants to the kinase inhibitors MLN518 and PD180970.

1 reference

12 December 2020

Mechanisms of drug combinations: interaction and network perspectives

1 reference

12 December 2020

Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy

1 reference

12 December 2020

HER2 oncogenic function escapes EGFR tyrosine kinase inhibitors via activation of alternative HER receptors in breast cancer cells

1 reference

12 December 2020

Flt-1-Dependent Survival Characterizes the Epithelial-Mesenchymal Transition of Colonic Organoids

1 reference

12 December 2020

Multi-target spectral moments for QSAR and Complex Networks study of antibacterial drugs.

1 reference

12 December 2020

The role of VEGF and EGFR inhibition: implications for combining anti-VEGF and anti-EGFR agents.

1 reference

12 December 2020

Phase II study of flavopiridol in patients with advanced colorectal cancer

1 reference

12 December 2020

Activity of the multikinase inhibitor dasatinib against ovarian cancer cells

1 reference

12 December 2020

Alignment-free prediction of a drug-target complex network based on parameters of drug connectivity and protein sequence of receptors.

1 reference

12 December 2020

Unify QSAR approach to antimicrobials. Part 1: predicting antifungal activity against different species.

1 reference

12 December 2020

"Bayes affinity fingerprints" improve retrieval rates in virtual screening and define orthogonal bioactivity space: when are multitarget drugs a feasible concept?

1 reference

12 December 2020

Results of dasatinib therapy in patients with early chronic-phase chronic myeloid leukemia

1 reference

12 December 2020

Classifying "kinase inhibitor-likeness" by using machine-learning methods.

1 reference

12 December 2020

Structure of the aspartic protease plasmepsin 4 from the malarial parasite Plasmodium malariae bound to an allophenylnorstatine-based inhibitor

1 reference

12 December 2020

Phase I and biomarker study of ABT-869, a multiple receptor tyrosine kinase inhibitor, in patients with refractory solid malignancies

1 reference

12 December 2020

Synergistic therapeutic actions of herbal ingredients and their mechanisms from molecular interaction and network perspectives

1 reference

12 December 2020

Flavopiridol: the first cyclin-dependent kinase inhibitor in human clinical trials

1 reference

12 December 2020

A comparison of physicochemical property profiles of marketed oral drugs and orally bioavailable anti-cancer protein kinase inhibitors in clinical development

1 reference

12 December 2020

A combination of cisplatin-eluting gelatin microspheres and flavopiridol enhances anti-tumour effects in a rabbit VX2 liver tumour model

1 reference

12 December 2020

Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies

1 reference

12 December 2020

Discovery of multitarget inhibitors by combining molecular docking with common pharmacophore matching

1 reference

12 December 2020

Synergistic activity of imatinib and 17-AAG in imatinib-resistant CML cells overexpressing BCR-ABL--Inhibition of P-glycoprotein function by 17-AAG.

1 reference

12 December 2020

Inhibition of phosphorylation of the colony-stimulating factor-1 receptor (c-Fms) tyrosine kinase in transfected cells by ABT-869 and other tyrosine kinase inhibitors

1 reference

12 December 2020

Prospect of a dopamine contribution in the next generation of antidepressant drugs: the triple reuptake inhibitors

1 reference

12 December 2020

Phase 1 clinical results with tandutinib (MLN518), a novel FLT3 antagonist, in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome: safety, pharmacokinetics, and pharmacodynamics

1 reference

12 December 2020

New pharmacological developments in the treatment of hepatocellular cancer

1 reference

12 December 2020

Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial

1 reference

12 December 2020

Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3

1 reference

12 December 2020

Monoamine oxidase and catecholamine metabolism

1 reference

12 December 2020

In-vitro and in-vivo characterization of JNJ-7925476, a novel triple monoamine uptake inhibitor

1 reference

12 December 2020

The influence of target family and functional activity on the physicochemical properties of pre-clinical compounds

1 reference

12 December 2020

Flavopiridol in chronic lymphocytic leukemia: a concise review

1 reference

12 December 2020

Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.

1 reference

12 December 2020

Src-family kinases in the development and therapy of Philadelphia chromosome-positive chronic myeloid leukemia and acute lymphoblastic leukemia

1 reference

12 December 2020

Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer

1 reference

12 December 2020

Antileukemic effects of the novel, mutant FLT3 inhibitor NVP-AST487: effects on PKC412-sensitive and -resistant FLT3-expressing cells

1 reference

12 December 2020

IQGAP1 modulates activation of B-Raf

1 reference

12 December 2020

Current combination chemotherapy regimens for metastatic breast cancer

1 reference

12 December 2020

Sorafenib inhibits the angiogenesis and growth of orthotopic anaplastic thyroid carcinoma xenografts in nude mice.

1 reference

12 December 2020

ZD-6474. AstraZeneca.

1 reference

12 December 2020

Early induction of apoptosis in hematopoietic cell lines after exposure to flavopiridol

1 reference

12 December 2020

Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia

1 reference

12 December 2020

Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition

1 reference

12 December 2020

Pazopanib, a potent orally administered small-molecule multitargeted tyrosine kinase inhibitor for renal cell carcinoma

1 reference

12 December 2020

In vivo target modulation and biological activity of CHIR-258, a multitargeted growth factor receptor kinase inhibitor, in colon cancer models

1 reference

12 December 2020

Evaluation of virtual screening performance of support vector machines trained by sparsely distributed active compounds.

1 reference

12 December 2020

Early clinical studies of novel therapies for thyroid cancers

1 reference

12 December 2020

The RET kinase inhibitor NVP-AST487 blocks growth and calcitonin gene expression through distinct mechanisms in medullary thyroid cancer cells

1 reference

12 December 2020

Targeting multiple kinases in glioblastoma multiforme

1 reference

12 December 2020

ABT-869, a multitargeted receptor tyrosine kinase inhibitor: inhibition of FLT3 phosphorylation and signaling in acute myeloid leukemia

1 reference

12 December 2020

Discovery of novel small-molecule inhibitors of human epidermal growth factor receptor-2: combined ligand and target-based approach.

1 reference

12 December 2020

Maximum common binding modes (MCBM): consensus docking scoring using multiple ligand information and interaction fingerprints

1 reference

12 December 2020

10.1007/S11095-010-0065-2

Identifiers

DOI

1 reference

22 August 2017

1 reference